• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

与巴西帕金森病患者 LRRK2 和 GBA 突变相关的临床特征。

Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease.

机构信息

Department of Genetics, Institute of Biology Roberto Alcantara Gomes, State University of Rio de Janeiro, Rio de Janeiro, Brazil.

Human Genetics Laboratory, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.

出版信息

J Neurol Sci. 2017 Oct 15;381:160-164. doi: 10.1016/j.jns.2017.08.3249. Epub 2017 Aug 24.

DOI:10.1016/j.jns.2017.08.3249
PMID:28991672
Abstract

BACKGROUND

Parkinson's disease (PD) is a neurodegenerative disorder characterized by remarkable phenotypic variability. Accumulated evidence points that the manifestation of PD clinical signs might be differentially modified by genetic factors, as mutations in LRRK2 and GBA genes. In this sense, the clarification of the genotype-phenotype correlations in PD has important implications in predicting prognosis and can contribute to the development of specific therapeutic approaches.

METHODS

Here, we conducted the first comparative analysis of motor and non-motor features in 17 LRRK2 and 22 GBA mutation carriers and 93 non-carriers unrelated PD patients from Brazil, a highly admixed population.

RESULTS

Significant differences were found between the three groups. LRRK2 PD patients presented more occurrence of familiar history. Resting tremor was observed in a lower frequency in GBA mutation carries. In contrast, gait freezing and dysautonomia was present in lower frequencies in LRRK2 carriers. Besides that, LRRK2 and GBA mutation carriers showed a higher incidence of depressive symptoms and a younger age at onset, when compared to non-carriers.

CONCLUSION

Our results suggest that specific mutations in GBA and LRRK2 influence the clinical signs of the disease, with significant implications for handling of specific patient groups.

摘要

背景

帕金森病(PD)是一种神经退行性疾病,其表型具有显著的可变性。越来越多的证据表明,PD 临床症状的表现可能受到遗传因素的不同影响,如 LRRK2 和 GBA 基因的突变。从这个意义上说,阐明 PD 的基因型-表型相关性对预测预后具有重要意义,并有助于开发特定的治疗方法。

方法

在这里,我们对来自巴西的 17 名 LRRK2 突变携带者、22 名 GBA 突变携带者和 93 名非携带者的运动和非运动特征进行了首次比较分析,巴西是一个高度混合的人群。

结果

三组之间存在显著差异。LRRK2 PD 患者家族史发生率更高。GBA 突变携带者中静止性震颤的发生频率较低。相反,LRRK2 携带者中步态冻结和自主神经功能障碍的发生频率较低。此外,与非携带者相比,LRRK2 和 GBA 突变携带者表现出更高的抑郁症状发生率和更年轻的发病年龄。

结论

我们的研究结果表明,GBA 和 LRRK2 中的特定突变影响疾病的临床症状,这对特定患者群体的处理具有重要意义。

相似文献

1
Clinical profiles associated with LRRK2 and GBA mutations in Brazilians with Parkinson's disease.与巴西帕金森病患者 LRRK2 和 GBA 突变相关的临床特征。
J Neurol Sci. 2017 Oct 15;381:160-164. doi: 10.1016/j.jns.2017.08.3249. Epub 2017 Aug 24.
2
Carriers of both GBA and LRRK2 mutations, compared to carriers of either, in Parkinson's disease: Risk estimates and genotype-phenotype correlations.帕金森病患者同时携带 GBA 和 LRRK2 突变与仅携带其中一种突变相比:风险估计和基因型-表型相关性。
Parkinsonism Relat Disord. 2019 May;62:179-184. doi: 10.1016/j.parkreldis.2018.12.014. Epub 2018 Dec 13.
3
Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.帕金森进展标志物倡议(PPMI)中无明显 LRRK2 和 GBA 突变携带者的临床和多巴胺转运体成像特征:一项横断面研究。
Lancet Neurol. 2020 Jan;19(1):71-80. doi: 10.1016/S1474-4422(19)30319-9. Epub 2019 Oct 31.
4
Glucocerebrosidase activity in Parkinson's disease with and without GBA mutations.伴有和不伴有GBA突变的帕金森病中的葡萄糖脑苷脂酶活性
Brain. 2015 Sep;138(Pt 9):2648-58. doi: 10.1093/brain/awv179. Epub 2015 Jun 27.
5
Prevalence of pre-diagnostic symptoms did not differ between LRRK2-related, GBA-related and idiopathic patients with Parkinson's disease.LRRK2 相关、GBA 相关和特发性帕金森病患者的预诊断症状的患病率没有差异。
Parkinsonism Relat Disord. 2018 Dec;57:72-76. doi: 10.1016/j.parkreldis.2018.08.007. Epub 2018 Aug 14.
6
Age at Onset of Parkinson's Disease Among Ashkenazi Jewish Patients: Contribution of Environmental Factors, LRRK2 p.G2019S and GBA p.N370S Mutations.帕金森病发病年龄在阿什肯纳兹犹太患者中的研究:环境因素、LRRK2 p.G2019S 和 GBA p.N370S 突变的作用。
J Parkinsons Dis. 2020;10(3):1123-1132. doi: 10.3233/JPD-191829.
7
Clinical and Dopamine Transporter Imaging Characteristics of Leucine Rich Repeat Kinase 2 (LRRK2) and Glucosylceramidase Beta (GBA) Parkinson's Disease Participants in the Parkinson's Progression Markers Initiative: A Cross-Sectional Study.LRRK2(富含亮氨酸重复激酶 2)和 GBA(β-葡糖苷脂酶)帕金森病患者的临床和多巴胺转运体成像特征:帕金森进展标志物倡议的横断面研究。
Mov Disord. 2020 May;35(5):833-844. doi: 10.1002/mds.27989. Epub 2020 Feb 19.
8
Autosomal dominant Parkinson's disease: Incidence of mutations in LRRK2, SNCA, VPS35 and GBA genes in Brazil.常染色体显性帕金森病:巴西LRRK2、SNCA、VPS35和GBA基因突变的发生率
Neurosci Lett. 2016 Dec 2;635:67-70. doi: 10.1016/j.neulet.2016.10.040. Epub 2016 Oct 21.
9
Cerebral Imaging Markers of GBA and LRRK2 Related Parkinson's Disease and Their First-Degree Unaffected Relatives.GBA和LRRK2相关帕金森病及其一级未患病亲属的脑成像标志物
Brain Topogr. 2018 Nov;31(6):1029-1036. doi: 10.1007/s10548-018-0653-8. Epub 2018 May 30.
10
Apathy: An underestimated feature in GBA and LRRK2 non-manifesting mutation carriers.淡漠:GBA 和 LRRK2 非表现型突变携带者中被低估的特征。
Parkinsonism Relat Disord. 2021 Oct;91:1-8. doi: 10.1016/j.parkreldis.2021.08.008. Epub 2021 Aug 18.

引用本文的文献

1
Exploring Risk and Protective Factors in Parkinson's Disease.探索帕金森病的风险因素和保护因素。
Cells. 2025 May 14;14(10):710. doi: 10.3390/cells14100710.
2
Machine learning study on predicting depressive symptoms and genetic correlations in Parkinson's disease.关于预测帕金森病抑郁症状及基因相关性的机器学习研究
Front Aging Neurosci. 2025 Apr 9;17:1584005. doi: 10.3389/fnagi.2025.1584005. eCollection 2025.
3
Freezing of gait in Parkinson's disease with glucocerebrosidase mutations: prevalence, clinical correlates and effect on quality of life.
患有葡萄糖脑苷脂酶突变的帕金森病患者的冻结步态:患病率、临床相关性及其对生活质量的影响。
Front Neurosci. 2023 Nov 28;17:1288631. doi: 10.3389/fnins.2023.1288631. eCollection 2023.
4
Frequency of Parkinson's Disease Genes and Role of in Amyotrophic Lateral Sclerosis: An NGS Study.帕金森病基因的频率与在肌萎缩侧索硬化症中的作用:一项 NGS 研究。
Genes (Basel). 2022 Jul 22;13(8):1306. doi: 10.3390/genes13081306.
5
LRRK2, GBA and their interaction in the regulation of autophagy: implications on therapeutics in Parkinson's disease.LRRK2、GBA 及其在自噬调节中的相互作用:对帕金森病治疗的影响。
Transl Neurodegener. 2022 Jan 31;11(1):5. doi: 10.1186/s40035-022-00281-6.
6
Freezing of gait: understanding the complexity of an enigmatic phenomenon.冻结步态:理解这一神秘现象的复杂性。
Brain. 2020 Jan 1;143(1):14-30. doi: 10.1093/brain/awz314.
7
The Missing Heritability of Sporadic Frontotemporal Dementia: New Insights from Rare Variants in Neurodegenerative Candidate Genes.散发性额颞叶痴呆的遗传缺失:神经退行性候选基因中罕见变异的新见解。
Int J Mol Sci. 2019 Aug 10;20(16):3903. doi: 10.3390/ijms20163903.
8
Autonomic Dysfunction in α-Synucleinopathies.α-突触核蛋白病中的自主神经功能障碍
Front Neurol. 2019 Apr 12;10:363. doi: 10.3389/fneur.2019.00363. eCollection 2019.
9
A Meta-Analysis of -Related Clinical Symptoms in Parkinson's Disease.帕金森病相关临床症状的荟萃分析。
Parkinsons Dis. 2018 Sep 27;2018:3136415. doi: 10.1155/2018/3136415. eCollection 2018.
10
Clinical Heterogeneity Among Variants in Parkinson's Disease: A Meta-Analysis.帕金森病变异体之间的临床异质性:一项荟萃分析。
Front Aging Neurosci. 2018 Sep 19;10:283. doi: 10.3389/fnagi.2018.00283. eCollection 2018.